TrialTransplantation and cellular therapy2021

Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.

Katherine C Rappazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.